Summary of Study ST001121
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000752. The data can be accessed directly via it's Project DOI: 10.21228/M8GD6N This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST001121 |
Study Title | Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part I) |
Study Summary | Urine metabolites are used in many clinical and biomedical studies, but usually only for a few classic compounds. Metabolomics detects vastly more metabolic signals that may be used to precisely define the health status of individuals. However, many compounds remain unidentified, hampering biochemical conclusions. Here, we annotate all metabolites detected using an untargeted metabolomics approach with a charged surface hybrid (CSH) assay on a Q Exactive HF mass spectrometry. |
Institute | University of California, Davis |
Department | Genome and Biomedical Sciences Facility |
Laboratory | WCMC Metabolomics Core |
Last Name | Blaženović |
First Name | Ivana |
Address | 1315 Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, Davis, CA 95616 |
ivana.blazenovic@gmail.com | |
Phone | (530) 754-8258 |
Submit Date | 2019-01-15 |
Total Subjects | 43 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2019-02-26 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000752 |
Project DOI: | doi: 10.21228/M8GD6N |
Project Title: | Lipidomic analysis of urine in patients with interstitial cystitis. |
Project Summary: | The urine of 43 patients with interstitial cystitis was analyzed using the WCMC lipidomics method. The target goal of this project is to identify urinary metabolites in patients with urological disorders. |
Institute: | University of California, Davis |
Department: | Genome and Biomedical Sciences Facility |
Laboratory: | WCMC Metabolomics Core |
Last Name: | Fiehn |
First Name: | Oliver |
Address: | 1315 Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, Davis, CA 95616 |
Email: | ofiehn@ucdavis.edu |
Phone: | (530) 754-8258 |
Subject:
Subject ID: | SU001182 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Condition |
---|---|---|
SA077842 | IC29_50 | Interstitial cystitis |
SA077843 | IC30_51 | Interstitial cystitis |
SA077844 | IC32_53 | Interstitial cystitis |
SA077845 | IC28_49 | Interstitial cystitis |
SA077846 | IC31_52 | Interstitial cystitis |
SA077847 | IC27_48 | Interstitial cystitis |
SA077848 | IC24_45 | Interstitial cystitis |
SA077849 | IC25_46 | Interstitial cystitis |
SA077850 | IC26_47 | Interstitial cystitis |
SA077851 | IC33_54 | Interstitial cystitis |
SA077852 | IC35_56 | Interstitial cystitis |
SA077853 | IC40_61 | Interstitial cystitis |
SA077854 | IC41_62 | Interstitial cystitis |
SA077855 | IC42_63 | Interstitial cystitis |
SA077856 | IC43_64 | Interstitial cystitis |
SA077857 | IC39_60 | Interstitial cystitis |
SA077858 | IC38_59 | Interstitial cystitis |
SA077859 | IC23_44 | Interstitial cystitis |
SA077860 | IC36_57 | Interstitial cystitis |
SA077861 | IC37_58 | Interstitial cystitis |
SA077862 | IC34_55 | Interstitial cystitis |
SA077863 | IC22_43 | Interstitial cystitis |
SA077864 | IC7_28 | Interstitial cystitis |
SA077865 | IC8_29 | Interstitial cystitis |
SA077866 | IC9_30 | Interstitial cystitis |
SA077867 | IC10_31 | Interstitial cystitis |
SA077868 | IC6_27 | Interstitial cystitis |
SA077869 | IC5_26 | Interstitial cystitis |
SA077870 | IC2_23 | Interstitial cystitis |
SA077871 | IC3_24 | Interstitial cystitis |
SA077872 | IC4_25 | Interstitial cystitis |
SA077873 | IC11_32 | Interstitial cystitis |
SA077874 | IC12_33 | Interstitial cystitis |
SA077875 | IC18_39 | Interstitial cystitis |
SA077876 | IC19_40 | Interstitial cystitis |
SA077877 | IC20_41 | Interstitial cystitis |
SA077878 | IC21_42 | Interstitial cystitis |
SA077879 | IC17_38 | Interstitial cystitis |
SA077880 | IC16_37 | Interstitial cystitis |
SA077881 | IC13_34 | Interstitial cystitis |
SA077882 | IC14_35 | Interstitial cystitis |
SA077883 | IC15_36 | Interstitial cystitis |
SA077884 | IC1_22 | Interstitial cystitis |
Showing results 1 to 43 of 43 |
Collection:
Collection ID: | CO001176 |
Collection Summary: | Urine samples were collected from 43 patients with interstial cystitis. Urine was frozen to -80°C and shipped to the WCMC on dry ice, where samples were stored at -80°C until analysis. |
Sample Type: | Urine |
Storage Conditions: | -80℃ |
Treatment:
Treatment ID: | TR001197 |
Treatment Summary: | Patients were not receiving any treatment at the time the urine was collected. |
Sample Preparation:
Sampleprep ID: | SP001190 |
Sampleprep Summary: | Samples were removed from the -80°C freezer and allowed to thaw on ice. 225 µL of MeOH with lipid internal standards was added to each sample. Samples were vortexed for 10 seconds. 750 µL of MTBE plus quality controls was added to each sample. Samples were vortexed for 10 seconds. 188 µL of LC-MS grade water was added to each sample. Samples were shaken at 4°C on an orbital mixing plate for 6 minutes. Samples were centrifuged for 2 minutes at 14,000 rcf. 2 aliquots of 350 µL were removed from the top, organic phase. One aliquot was stored at -20°C for backup and the other was dried using a Labconco centrivap. 2 aliquots of 125 µL of the bottom polar phase were removed. One aliquot was stored at -20°C for backup and the other was dried using a Labconco centrivap. |
Sample Resuspension: | For lipidomics analysis, samples were resuspened in 110 µL of 9:1 methanol:toluene with 50 nM of CUDA as an internal standard. Samples were vortexed for 10 seconds and then sonicated in room temperature water for 5 minutes. Samples were run in a centrifuge for 2 minutes at 16,100 rcf. 100 µL of the supernatant was removed and submited to lipidomics analysis. |
Combined analysis:
Analysis ID | AN001846 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Thermo Vanquish |
Column | Waters Acquity CSH C18 (100 x 2.1mm,1.7um) |
MS Type | ESI |
MS instrument type | Orbitrap |
MS instrument name | Thermo Q Exactive HF hybrid Orbitrap |
Ion Mode | POSITIVE |
Units | Peak Height |
Chromatography:
Chromatography ID: | CH001323 |
Instrument Name: | Thermo Vanquish |
Column Name: | Waters Acquity CSH C18 (100 x 2.1mm,1.7um) |
Column Pressure: | 600 bar - 900 bar |
Column Temperature: | 65°C |
Flow Gradient: | 0 min 15% B; 0−2 min 30% B; 2−2.5 min 48% B; 2.5−11 min 82% B; 11−11.5 min 99% B; 11.5−12 min 99% B; 12−12.1 min 15% B; 12.1−15 min 15% B. |
Flow Rate: | 600 µL/min |
Internal Standard: | 50 nM CUDA |
Sample Injection: | 1 µL |
Solvent A: | 40% water/60% acetonitrile; 0.1% formic acid; 10 mM ammonium formate |
Solvent B: | 90% isopropanol/10% acetonitrile; 0.1% formic acid; 10 mM ammonium formate |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS001707 |
Analysis ID: | AN001846 |
Instrument Name: | Thermo Q Exactive HF hybrid Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Data was processing using X-Calibur Qual Browser, MS-Dial, and MS-Flo following the data processing procedure outlined by the WCMC. |
Ion Mode: | POSITIVE |